bioAffinity Technologies Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio1.515.522788.17
P/B Ratio5.452.881.21
Price/Tangible Book33.575.341.21
Enterprise Value Ratios
EV/Revenue1.624.40147.57
Profitability & Returns
Return on Equity (ROE)-2.42%-1.00%
Return on Assets (ROA)-0.76%-0.49%-0.37%-1.73%
Return on Capital Employed (ROCE)-2.63%-1.33%-0.36%0.19%0.24%
Leverage & Solvency Ratios
Debt/Equity0.580.330.02-0.97-0.91
Liquidity Ratios
Current Ratio0.871.7710.510.110.01
Quick Ratio0.721.6210.030.100.01
Efficiency Ratios
Asset Turnover1.270.250.00
Inventory Turnover259.63144.93
Yield & Distribution Ratios
Earnings Yield-0.64%-0.57%-0.61%
FCF Yield-0.52%-0.43%-0.32%
Buyback Yield-0.39%-0.94%-0.68%0.00%